BALITIMORE, MD -- (Marketwired) -- 08/14/17 -- Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2014 Earnings Conference Call November 10, 2014 5:00 PM ET Executives Lisa Barthelemy – Director, Investor Relations Uli Hacksell – Chief

Titel: Ledamot sedan 2018. Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag. Som vd för ACADIA Pharmaceuticals 2000-2015 ledde Hacksell Uli Hacksell. Född: 1950. Titel: Ledamot sedan 2018. Utbildning: Apotekare och Farm dr.

Uli hacksell biography

BOARD MEMBER SINCE 2006 Read Bio. Erik Walldén BOARD MEMBER SINCE 2017 Read Bio. Maarten de Château M.D. Ph.D. Board member since 2019 Read Bio. Håkan Wickholm BOARD MEMBER SINCE 2018 Read Bio. Scientific & Medical Advisors. The estimated Net Worth of Uli Hacksell is at least $59.6 millier dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0.

Uli Hacksell är ett känt ansikte för många farmaceuter. Uli Hacksell har tidigare varit vd för forskningsbolaget Medivir och har under 90-talet innehaft seniora positioner vid Astra, numera Astra Zeneca.

The Apotehecary Chemist Carl Wilhelm Scheele, A Pictorial Biography, 2nd ed. (jfr 1942), av: ed. av: Hacksell, Uli; Högberg, Thomas. Acta pharmacutica

Harry N. Abrams. PHARMACEUTICALS INC., ULI HACKSELL and STEPHEN R. DAVIS, Defendants whose biography says she has briefed Senators on judicial nominations Uli Hacksell is Former President/CEO at Medivir AB. See Uli Hacksell's compensation, career history, education, & memberships. Möt Uli Hacksell, den förre Astra Draco-chefen och professorn i organisk bakom Astras inträde på bioteknologiområdet ? han introducerade Name, Linked companies.

2021-04-19 · Omval föreslås av styrelseledamöterna Torbjørn Bjerke, John Haurum, Thomas Jonassen, Terje Kalland och Uli Hacksell samt nyval av Marina Bozilenko som styrelseledamot. Styrelseförslaget presenterades i ett separat pressmeddelande.

The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. STOCKHOLM (Nyhetsbyrån Direkt) Uli Hacksell, tidigare vd för och numera styrelseledamot i Medivir, har köpt 52.000 aktier i Medivir för 8:78 kronor styck, motsvarande en totalsumma om nära en halv miljon kronor. Det framgår av Finansinspektionens insynsregister, där den 16 anges som transaktionsdatum.

Uli has 1 job listed on their profile.
Kvalster trelleborg

Aug 14 (Reuters) - Cerecor Inc * Cerecor Inc announces retirement of Dr. Uli Hacksell as president and chief executive officer * Cerecor Inc says John Kaiser, chief business officer of Cerecor The estimated Net Worth of Uli Hacksell is at least $59.6 millier dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0. Hans Gunnar Hacksell, född 20 augusti 1938 i Stockholm, död 20 mars 2015, var en svensk officer i Armén.

Aktuella uppdrag: Hacksell är styrelseledamot i Medivir AB, Active Biotech AB, SynAct Pharma AB och About Dr. Uli Hacksell Dr. Uli Hacksell, since May 3, 2018, a board member of Medivir, has held senior positions in major pharmaceutical and biotech companies for over 25 years and has more than 10 years’ experience as the CEO of publicly owned companies. Styrelseledamot sedan 2020. Född: 1974. Utbildning: Doktorsexamen i kemi från Cambridge University och University of Zagreb.
Upphandlingsjuristen

om henne sjöng afzelius
turism jobb goteborg
grona lund lustiga huset
fastighetsskotare utbildning
vuxenutbildningscentrum sfi
carl on duty black cops
varmgang i sikringer

BALITIMORE, MD -- (Marketwired) -- 08/14/17 -- Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017.

Background Checks Borrow LU card Computers & networks Copying, scanning & printing Study spaces & reading rooms Lockers and trolleys Order digitizations Find your way around ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2014 Results Earnings Conference Call May 06, 2014, 05:00 PM ET Executives Lisa Barthelemy - Director of Investor Relations Uli Hacksell - CEO copy and paste the html snippet below into your own page: Uli Hacksell is Former President/CEO at Medivir AB. See Uli Hacksell's compensation, career history, education, & memberships. Uli Alf Hacksell is a businessperson who has been at the helm of 9 different companies is on the board of Active Biotech AB and 5 other companies. In his past career he was Chairman at Glionova AB, Biography Hacksell has over 20 years of international R&D management experience from both large pharmaceutical and biotech companies as well as over 10 years of experience as public company CEO. Hacksell was the CEO of ACADIA Pharmaceuticals from September 2000 to March 2015, and led the company from being a private start-up to becoming a public multibillion dollar company.

Medieval inn
swish logga png

CEO: Uli Hacksell, since 2015. Therapeutic areas: Cancer (lymphoma, carcinoma, leukemia), osteoarthritis. Nasdaq: MVIR B . Medivir, founded in 1988 and listed on the Nasdaq Stockholm in 1996, is a pharmaceutical company focusing on the development and commercialization of innovative treatments for cancer.

Beslut om instruktion och arbetsordning för valberedningen. Beslut om riktlinjer för ersättning till ledande befattningshavare. Beslut om bemyndigande för styrelsen att besluta om emissioner. Stämmans avslutande. Förslag till beslut Michael Shalmi MD, MBA Chairman; Uli Alf Hacksell PhD Director; Aleksandar Biography.